Cerebral Palsy Diagnosis, Treatment May Be Improved by Speech Research

A Scottish university believes it could be on the verge of improving the speech of children suffering from cerebral palsy (CP).  

The University of Strathclyde in Glasgow issued a press release last week, announcing a new project to analyze the speech patterns of children affected by cerebral palsy.

Dr. Anja Kuschmann will lead the new research, which she suggests may lead to improved cerebral palsy diagnosis and speech therapy.

Sports-Betting-Addiction-Lawsuits
Sports-Betting-Addiction-Lawsuits

“Many children with CP have difficulties with speech melody, rhythm and stress. These difficulties, generally referred to as prosodic difficulties, can affect the intelligibility of a child’s speech, and are therefore of great clinical importance,” Kuschmann said in the press release. “However, the development of prosody in children is not well understood. As a result, it is not certain whether prosodic difficulties in CP are due to muscular problems during speaking or the inability to build and store the correct prosodic information in the brain.”

Kuschmann said that the three-year project will try to determine the underlying nature of the difficulties of speech faced by children with CP. Although there is no cure for cerebral palsy, therapy can often help increase the independence of people with the condition.

Cerebral palsy involves serious bran damage that can occur before, during or shortly after birth. If the brain of a baby is deprived of oxygen, it can result in irreversible damage that leaves the child with developmental problems, loss of motor functions and other life-long injuries and disabilities.

Although cerebral palsy can occur without a medical mistake, when the exercise of the proper standards of medical care could have prevented the child’s brain from being deprived of oxygen, cerebral palsy negligence lawsuits are often filed to obtain compensation for the child.

Written by: Irvin Jackson

Senior Legal Journalist & Contributing Editor

Irvin Jackson is a senior investigative reporter at AboutLawsuits.com with more than 30 years of experience covering mass tort litigation, environmental policy, and consumer safety. He previously served as Associate Editor at Inside the EPA and contributes original reporting on product liability lawsuits, regulatory failures, and nationwide litigation trends.




0 Comments


This field is for validation purposes and should be left unchanged.

Share Your Comments

This field is hidden when viewing the form
I authorize the above comments be posted on this page
Post Comment
Weekly Digest Opt-In

Want your comments reviewed by a lawyer?

To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

MORE TOP STORIES

A Florida jury has ordered Johnson & Johnson to pay $20 million to the family of a man who died of mesothelioma after using the company’s talc-based products for 50 years.
Sanofi indicates Dupixent sales are growing stronger as the medication gathers more indications for use worldwide, despite recent cancer concerns.